At close: 12:14:36 PM GMT+11
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
Total Revenue
152.2400
152.2400
3.0760
--
Gross Profit
152.2400
152.2400
3.0760
--
Operating Expense
6,668.5400
6,668.5400
5,743.4080
4,225.5460
Operating Income
-6,516.3000
-6,516.3000
-5,740.3320
-4,225.5460
Net Non Operating Interest Income Expense
743.3760
743.3760
430.1570
39.7760
Other Income Expense
1,634.8200
1,634.8200
1,135.7610
-2,651.8190
Pretax Income
-4,138.1040
-4,138.1040
-4,174.4140
-6,837.5890
Net Income Common Stockholders
-4,138.1040
-4,138.1040
-4,174.4140
-6,837.5890
Basic EPS
-0.07
--
-0.07
-0.14
Diluted EPS
-0.07
--
-0.07
-0.14
Basic Average Shares
60,464.8430
--
60,464.8430
49,763.5290
Diluted Average Shares
60,464.8430
--
60,464.8430
49,763.5290
Net Income from Continuing & Discontinued Operation
-4,138.1040
-4,138.1040
-4,174.4140
-6,837.5890
Normalized Income
-4,138.1040
-4,138.1040
-4,174.4140
-6,837.5890
Interest Income
743.3760
743.3760
430.1570
39.7790
Interest Expense
--
--
--
0.0030
Net Interest Income
743.3760
743.3760
430.1570
39.7760
EBIT
-6,516.3000
-6,516.3000
-5,740.3320
-6,837.5860
EBITDA
-6,514.5710
-6,514.5710
-5,737.6840
-6,835.8730
Reconciled Depreciation
1.7290
1.7290
2.6480
1.7130
Net Income from Continuing Operation Net Minority Interest
-4,138.1040
-4,138.1040
-4,174.4140
-6,837.5890
Normalized EBITDA
-6,514.5710
-6,514.5710
-5,737.6840
-6,835.8730
6/30/2022 - 11/17/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
VBS.AX Vectus Biosystems Limited
0.0770
0.00%
ZLD.AX Zelira Therapeutics Limited
0.6000
0.00%
PTX.AX Prescient Therapeutics Limited
0.0410
-2.38%
SPL.AX Starpharma Holdings Limited
0.1150
0.00%
TYP.AX TRYPTAMINE FPO [TYP]
0.0420
0.00%
PYC.AX PYC Therapeutics Limited
1.5100
-0.66%
RAC.AX Race Oncology Limited
1.3700
-1.44%
RCE.AX Recce Pharmaceuticals Ltd
0.4750
-6.86%
RAD.AX Radiopharm Theranostics Limited
0.0280
-6.67%
TLX.AX Telix Pharmaceuticals Limited
24.11
-0.17%